FDA Investigator Elodie Xtong Lin

Elodie Xtong Lin has inspections in 3 countries as of 15 Sep 2023. Elodie Xtong Lin has collaborated with a combinined 3284 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
98
Last Inspection Date:
15 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100005372
Country:
United States of America, Germany
Co-Investigator(s):
Alex G Kalugin, Alexis R Ajello, Alice A Blair, Alla Dubrovsky, Amanda N Schaupp, Amogh Pathi, Andersoneric, Andrew B Slarve, Andrew E Kay, Andrew T Todd, Angel K Sandhu, Angela D Wise, Anna L Viveros Hernandez, Annie H Lam, Ashar P Parikh, Bak, Baker, Belinda E Clifton, Benny Y Gong, Blair, Bowman, Brian R Henderson, Bruce D Broidy, Camacho, Capri R Woolridge, Carr, Carr Sharpe, Carrie E Thrasher, Celeste K Wong, Chan, Chloe Anne Leong, Christine M Parmentier, Cindy W Lewis, Courtney R Bolton, Craig K Hopkins, Cynthia L Ford, Damon A Growl, Daniel C Geffin, Daniel J Roberts, Daniel Velasquez, Darla R Bracy, David G Eng, David J Leray, David P Moorhead, Davis, Deborah K Richardson, Debra C Yamane, Debra D Devlieger, Debra J Fracassa, Dena L Jacobs, Denise Connelly, Durell L Giles, Edna J Hidalgo, Edwards, Eileen T Dupont, Elisabeth A Drevet, Emal Wahab, Emmanuel O Kerry, Eric C Nielsen, Eric J Heinze, Erica Fernandez, Erica R Pomeroy, Estefania Fernandez, Foley, Francisco, Frank P Bianco, Frans E Mercado, Gillenwater, Greg K Keshishyan, Gulshan R Anand, Helen J Hamaoka, Holly A Rhodes, Indigo A Doll, Ingrid A Zambrana, Ismael Garibay, James C Lee, PharmD, James C Yee, Jane Chen, Janice R Small, Janice Wai, Jazmine M Welcher, Jeanne A Young, Jeffrey W Shrifter, DPM, Jennifer Crumb, Jennifer L Johnson, Jennifer S King, Jenny K Yee, Jessica B Clark, Jessica B Darneille, Joan T Briones, Joanne M Fukuda, Jocelyn T Ramos, John A Liu, John R Myung, Jolene S Hedgecock, Jonathon A Yenovkian, Joseph M Willems, Joseph Tibay, Juan A Morales, Judy C Nepsa, Kacie M Crowther, Karen D Phung, Karen J Bak, Karla J Gibler, Katie T Duong, Kavita K Lalwani, Kawshalya Pathiraja, Kevin Lee, Kevin P Foley, Kevin T Gerrity, Khanh T Van, Kimberly L Anderson, Kin T Moy, Kristin M Abaonza, Krystina M Jackson, Lance A Finnical, Larkin R Buckalew, Lawton W Lum, Lea Lakes, Lee, Leongc, Lija V Fellows, Lilly O Barton, Lillyj, Linda Linh T Nguyen, Linda S Shook, Lisa H Nakagawa, Lorraine N Dixon, Lorraine N Williams, Lourdes Andujar, LT Mark A Chen, MPH, Lydia S Chan, Lynn L Wong, Mabel M Lee, Macropolk, Maida Henesian (NMI), Margo C Jones, Margo Cl Jones, Maridali De Leon Torres, Marissa J Chan, Mark E Baldwin, Mark I Nakano, Mark L Collins, Mary C Acton, Mary C Wall, Mary R Hole, Matthew A Walburger, Mcgrewp, Melody M Ragasa Leong, Melvin Dorin, Michael J Jackson, Michelle L Tripp, Monique C Lo, Naveen B Walker, Ngoc B Kelsch, Nicole Yuen, Noelani K Chiu, Nympha V Florendo, Patricia F Alberico, Patrick E Gainer, Peter E Baker, Phung, Quynh H Strandberg, Rachel J Cantrell, Randall F Albright, Randall J Plunkett, Randall P Zielinski, Rashonda N Rucker, Raymond Souweha, Robert P Neligan, Roberta K Smith, Ronald P Boyce, Rumany C Penn, PharmD, Samuel J Barone, III, Sandra S Saniga, Sara M Richardson, Savannah E Samp, Scott J Matsuda, Sean P Desbrow, Selene T Torres, Sharon L Shane, Siobhan A Gallagher, Sparky L Bartee, State Agency, Steve P Yost, Steven B Chiu, Steven M Galvez, Stuart Kim, Stuart W Russell, Sundy V Sedwick, Teresa I Navas, Terrence Gee, Thomas N Adjabeng, Timothy C Grome, Tomanik'e C Banks, Travelle D Mason, Vebina K Sethi, Vi T Au, Victoria L Morgan, Wayne L Jefferson, Wen Jun Peng, Wendy S Shenk, William J Foust, William J Weis, Yen Tso Kuo

Elodie Xtong Lin's Documents

Publish Date Document Type Title
May, 2017 FDA 483 Harbinger Group, LLC. dba Misionero - Form 483, 2017-05-12
March, 2017 FDA 483 Hanbit Enterprises Inc. dba Jack and the Bean Stalk - Form 483, 2017-03-07
August, 2017 EIR Mann Packing LLC. - EIR, 2017-08-09
April, 2017 FDA 483 Christopher Ranch LLC - Form 483, 2017-04-19

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more